Verification of HE-based CTV in Laryngeal and Hypopharyngeal Cancer Using Pan-cytokeratin

Overview

Journal Clin Transl Radiat Oncol

Specialty Oncology

Date 2018 Aug 11

PMID 30094352

Citations 1

Authors

Hans Ligtenberg

Stefan M Willems

Lilian N Ruiter

Elise Anne Jager

Chris H J Terhaard

Cornelis P J Raaijmakers

Marielle E P Philippens

Affiliations

Soon will be listed here.

Abstract

Background: For accurate target definition, we determined margins for the clinical target volume (CTV) for laryngeal and hypopharyngeal cancer in computed tomography (CT, 4.3 mm), magnetic resonance imaging (MR, 6.1 mm) and fluorodeoxyglucose (FDG)-positron emission tomography (PET, 5.2 mm). Previously, we used Hematoxylin-eosin (HE) stained whole-mount sections of total laryngectomy specimens as gold standard to define CTV margins. In the present study, we verified the HE-based tumor delineation with staining for pan-cytokeratin, specific for squamous cell carcinoma.

Methods: Twenty-seven patients with a T3/T4 laryngeal hypopharyngeal tumor were included. From each patient, a total laryngectomy specimen was obtained. Four subsequent 3-mm thick slices containing tumor were selected of which 4-µm thick whole-mount sections were obtained and stained with HE and for pan-cytokeratin CK-AE1/3. Tumors were microscopically delineated on both sections by an experienced head-and-neck pathologist. Tumor delineations were compared using the conformity index (CI) and the distance between both contours.

Results: The CI between HE-based and CK-AE1/3-based tumor delineations was 0.87. The maximum and 95th percentile (p95) extent of the HE-based tumor delineations from the CK-AE1/3-based tumor delineations were 1.7 mm and 0.7 mm, respectively. The maximum and p95 extent of the CK-AE1/3-based tumor delineations from the HE-based tumor delineations was 1.9 mm and 0.8 mm, respectively.

Conclusions: Histopathological assessment of tumor outline on standard HE-stained sections is comparable to microscopic tumor extent based on squamous cell specific pan-cytokeratin staining. Therefore, CTV margins based on HE based tumor contour will be adequate.

Citing Articles

The Role of a Minimum Immunohistochemical Antibody Panel in Confirming Undifferentiated Nasopharyngeal Carcinoma: A Cross-Sectional Study at the Muhimbili National Hospital, Dar-es-Salaam, Tanzania.

Mremi A, Yahaya J, Abraham Z, Mwakigonja A Niger Med J. 2020; 60(6):279-284.

PMID: 32180656 PMC: 7053275. DOI: 10.4103/nmj.NMJ_134_19.

References

Rasch C, Steenbakkers R, Van Herk M . Target definition in prostate, head, and neck. Semin Radiat Oncol. 2005; 15(3):136-45. DOI: 10.1016/j.semradonc.2005.01.005. View

Caldas-Magalhaes J, Kasperts N, Kooij N, van den Berg C, Terhaard C, Raaijmakers C . Validation of imaging with pathology in laryngeal cancer: accuracy of the registration methodology. Int J Radiat Oncol Biol Phys. 2011; 82(2):e289-98. DOI: 10.1016/j.ijrobp.2011.05.004. View

Costa Ferreira B, Marques R, Khouri L, Santos T, Sa-Couto P, do Carmo Lopes M . Assessment and topographic characterization of locoregional recurrences in head and neck tumours. Radiat Oncol. 2015; 10:41. PMC: 4619282. DOI: 10.1186/s13014-015-0345-4. View

Vinod S, Jameson M, Min M, Holloway L . Uncertainties in volume delineation in radiation oncology: A systematic review and recommendations for future studies. Radiother Oncol. 2016; 121(2):169-179. DOI: 10.1016/j.radonc.2016.09.009. View

Fleury B, Thariat J, Barnoud R, Buiret G, Lebreton F, Bancel B . [Microscopic extensions of head and neck squamous cell carcinomas: impact for clinical target volume definition]. Cancer Radiother. 2014; 18(7):666-71. DOI: 10.1016/j.canrad.2014.04.006. View

Campbell S, Poon I, Markel D, Vena D, Higgins K, Enepekides D . Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers. Int J Radiat Oncol Biol Phys. 2011; 82(2):574-81. DOI: 10.1016/j.ijrobp.2010.09.038. View

Ligtenberg H, Jager E, Caldas-Magalhaes J, Schakel T, Pameijer F, Kasperts N . Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI. Radiother Oncol. 2017; 123(1):63-70. DOI: 10.1016/j.radonc.2017.02.005. View

Jager E, Ligtenberg H, Caldas-Magalhaes J, Schakel T, Philippens M, Pameijer F . Validated guidelines for tumor delineation on magnetic resonance imaging for laryngeal and hypopharyngeal cancer. Acta Oncol. 2016; 55(11):1305-1312. DOI: 10.1080/0284186X.2016.1219048. View

Yuen P, Lam K, Chan A, Wei W, Lam L . Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg. 1998; 175(3):242-4. DOI: 10.1016/s0002-9610(97)00282-1. View

10.

van der Velden L, Schaafsma H, Manni J, Ruiter D, Ramaekers F, Kuijpers W . Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol. 1997; 254(8):376-83. DOI: 10.1007/BF01642554. View

11.

Zukauskaite R, Hansen C, Grau C, Samsoe E, Johansen J, Petersen J . Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. Radiother Oncol. 2017; 126(1):48-55. DOI: 10.1016/j.radonc.2017.11.024. View

12.

Leclerc M, Lartigau E, Lacornerie T, Daisne J, Kramar A, Gregoire V . Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. Radiother Oncol. 2015; 116(1):87-93. DOI: 10.1016/j.radonc.2015.06.007. View

13.

Van Cann E, Rijpkema M, Heerschap A, van der Bilt A, Koole R, Stoelinga P . Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma. Oral Oncol. 2008; 44(12):1147-54. DOI: 10.1016/j.oraloncology.2008.02.009. View

14.

Bayman E, Prestwich R, Speight R, Aspin L, Garratt L, Wilson S . Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation. Clin Oncol (R Coll Radiol). 2014; 26(10):636-42. DOI: 10.1016/j.clon.2014.05.001. View

15.

Caldas-Magalhaes J, Kooij N, Ligtenberg H, Jager E, Schakel T, Kasperts N . The accuracy of target delineation in laryngeal and hypopharyngeal cancer. Acta Oncol. 2015; 54(8):1181-7. DOI: 10.3109/0284186X.2015.1006401. View

16.

Bol G, Kotte A, van der Heide U, Lagendijk J . Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed. 2009; 96(2):133-40. DOI: 10.1016/j.cmpb.2009.04.008. View

17.

Vugts C, Terhaard C, Philippens M, Pameijer F, Kasperts N, Raaijmakers C . Consequences of tumor planning target volume reduction in treatment of T2-T4 laryngeal cancer. Radiat Oncol. 2014; 9:195. PMC: 4261247. DOI: 10.1186/1748-717X-9-195. View

18.

Gregoire V, Evans M, Le Q, Bourhis J, Budach V, Chen A . Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG.... Radiother Oncol. 2017; 126(1):3-24. DOI: 10.1016/j.radonc.2017.10.016. View

19.

Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P . Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 1995; 194(3):661-9. DOI: 10.1148/radiology.194.3.7862960. View

20.

Jager E, Willems S, Schakel T, Kooij N, Slootweg P, Philippens M . Interobserver variation among pathologists for delineation of tumor on H&E-sections of laryngeal and hypopharyngeal carcinoma. How good is the gold standard?. Acta Oncol. 2015; 55(3):391-5. DOI: 10.3109/0284186X.2015.1049661. View